December 24, 2012
A familiar name will ascend to the CEO chair of Medical Research South as the New Year dawns. Sean Rice, presently V.P. Finance & Operations, takes the helm on January 1st while Barry Lake remains fully engaged on overall strategy as Executive Chairman.
“Sean certainly has a wide-ranging skill set,” stated Lake, “I know I speak for the entire ownership group when I say we are thrilled to have someone of his caliber leading Medical Research South in the next phase of our growth.”
Rice’s appointment will certainly come as no surprise to the staff at Medical Research South since Sean and his wife, Shannon, relocated to Charleston earlier this year making him a consistent presence in the Medical Research South office. The Vinco Capital ownership group’s desire to have a trusted manager in the office on a daily basis was the driving factor for the Rice’s move to Charleston but, Sean and Shannon and their new labradoodle puppy, Sophie, are very much enjoying all the city has to offer. “From a big city perspective Charleston offers numerous four star restaurants and countless activities but it has a small city feel and you rarely encounter traffic issues despite it being one of the most popular tourist destinations in the country.”
Sean attended Alma College, completing a B.A. in Accounting and started a career at Deloitte & Touche. He then joined Commonwealth Aluminum (now Aleris International) as a Risk Specialist based in their Louisville, Kentucky office. In 2004, Rice joined Genscape, Inc. a firm that developed a technology platform that provided real-time supply information to the energy industry. Sean ascended the executive ranks with Genscape, a two-time Inc. 500 Fastest Growing Company in the U.S., eventually becoming V.P. Finance. Tiring of the compliance issues inherent in being part of a publicly-held parent, Rice jumped at the chance to join Vinco Capital in 2009 since it afforded him the opportunity to thrive in a truly entrepreneurial environment.
“Sean knows Medical Research South inside and out,” emphasized Barry Lake, Vinco Capital’s President, “He led our due diligence team through the acquisition in late 2010 and has been the key operating manager in Charleston. I have no doubt that he will successfully execute our vision for Medical Research South.”
That vision includes seeing the company grow, both organically and through acquisition, from its single base of operations in Charleston into a multi-site network of Clinical Trial Management branches across South Carolina. As Rice clearly articulates “The clinical research industry is highly fragmented requiring pharmaceutical company sponsors and CRO’s to identify multiple small sites across the U.S. to reach their patient enrollment goals. Unfortunately, from the sponsor’s perspective, this diversity of sites leads to a lack of consistency in terms of a site’s ability to enroll qualified patients and provide timely and accurate data. Medical Research South’s network of well-managed sites will help alleviate this problem, allowing medical advances to be brought to market a lot faster.”
Medical Research South expects to begin expanding in 2013. With plans to establish a second branch by year end, the strategic vision of the management team is soon to become a reality.
Medical Research South is a full-time Manager of Clinical Research Trials for the biggest names in the pharmaceutical industry. The flagship office in Charleston, South Carolina, provides a warm, caring environment for patients, treating them like the exceptional people they are, in direct contrast to the typical hospital or physician’s office experience. Medical Research South can be reached at 855-MEDSOUTH (633-7688), email firstname.lastname@example.org.